New York (1)

Metastatic Salivary Gland Carcinoma (1)

Recurrent Salivary Gland Carcinoma (1)

Stage III Major Salivary Gland Cancer AJCC v8 (1)

Stage IV Major Salivary Gland Cancer AJCC v8 (1)

Unresectable Salivary Gland Carcinoma (1)

Recruiting (1)

phase 2 (1)

NRG Oncology (1)

National Cancer Institute (NCI) (1)

docetaxel (1)

questionnaire administration (1)

trastuzumab (1)

trastuzumab emtansine (1)

biological (1)

drug (1)

other (1)

Other (1)

Interventional (1)

stage iii major salivary gland cancer ajcc v8

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Jan 11, 2023